Stocks
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately $0.2229 per share, continuing the buyback activity carried out under its ongoing repurchase program. The Company has now repurchased a total of 3,640,000 shares for approximately $7
About this update from Cosmos Health Inc.
CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately $0.2229 per share, continuing the buyback activity carried out under its ongoing repurchase program. The Company has now repurchased a total of 3,640,000 shares for approximately $700,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may buy back shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions. The Company intends to continue making open market purchases, subject to market conditions, under the program, which expires on December 31, 2026, and may be renewed at the Company's sole discretion. Greg Siokas, CEO of Cosmos Health, stated: "Each additional repurchase underscores our conviction that Cosmos Health's shares remain undervalued relative to the strength of our operations and the long-term potential of our global platform. Returning capital to shareholders through these buybacks continues to be one of the most compelling investments available to us, and we remain committed to that path." About Cosmos Health Inc.Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and...
View stock analysis, news, and events for Cosmos Health Inc.